US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.56

-0.4392-0.98%

Post-market: 44.56-0.0038-0.01%19:30 EDT

Volume:9K

Turnover:402.62K

Market Cap:42.34M

PE:- -

High:45.50

Open:45.50

Low:44.26

Close:45.00

52wk High:56.18

52wk Low:27.62

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.40

T/O Rate:0.95%

Dividend:0.66

Dividend Rate:1.47%

ROE:--

ROA:--

PB:0.96

PE(LYR):- -

Loading ...

Overview Company News Filings

The BBC’s bulletin cuts show how crowded sports broadcasting has become

BioAge Labs initiates Phase 2 trial for BGE-102

Abogen announces licensing, option agreement with Novartis

UK Prime Minister Says Iran May Be Linked to Security Incident at RAF Fairford Air Base

Verrica Pharmaceuticals to present new YCANTH data at upcoming conferences

Jade Biosciences advances JADE301 toward Phase 1 trial

Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety

MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001

C4 Therapeutics Reports New Cemsidomide Myeloma Data

Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race

Psychedelic: Optimi completes psilocybin production for Phase 2 trial

BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033

AC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-7104

Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY

Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138

Avalyn Pharma announces published results from Phase 1 trials of AP02

Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial

Cue Biopharma announces Phase 2 trial of CUE-221 met primary endpoint

US Claims Permanent Control While Denmark Rejects Sovereignty Transfer: Who Truly Benefits from the Greenland Deal?

Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/BBC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":44.5638,"timestamp":1790971200000,"preClose":45.003,"halted":0,"volume":9007,"hourTrading":{"tag":"盘后","latestPrice":44.56,"preClose":44.5638,"latestTime":"19:30 EDT","volume":13,"amount":579.258,"timestamp":1790983804096,"change":-0.0038,"changeRate":-0.000085,"amplitude":0},"delay":0,"changeRate":-0.00975934937670821,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Market Closed","change":-0.4392,"latestTime":"10-02 16:00:00 EDT","open":45.5,"high":45.5,"low":44.26,"amount":402619.38503999996,"amplitude":0.027554,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":45.003,"sharesOutstanding":900004,"nav":44.548,"aum":42321005.38,"dividendRate":0.014714,"bidAskSpread":0.002193,"postHourTrading":{"tag":"盘后","latestPrice":44.56,"preClose":44.5638,"latestTime":"19:30 EDT","volume":13,"amount":579.258,"timestamp":1790983804096,"change":-0.0038,"changeRate":-0.000085,"amplitude":0},"volumeRatio":0.40334787043929554,"impliedVol":0.3288,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.40334787043929554,"shares":950000,"dividePrice":0.6557,"high":45.5,"amplitude":0.027554,"preClose":45.003,"low":44.26,"week52Low":27.62,"pbRate":"0.96","week52High":56.18,"institutionHeld":0,"latestPrice":44.5638,"eps":0,"divideRate":0.014714,"volume":9007,"delay":0,"ttmEps":0,"open":45.5,"prevYearClose":38.56,"prevWeekClose":45.1452,"prevMonthClose":46.2948,"prevQuarterClose":46.2948,"fiveDayClose":45.1452,"twentyDayClose":53.39,"sixtyDayClose":54.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672722351","title":"The BBC’s bulletin cuts show how crowded sports broadcasting has become","url":"https://stock-news.laohu8.com/highlight/detail?id=2672722351","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672722351?lang=en_us&edition=fundamental","pubTime":"2026-10-04 12:00","pubTimestamp":1791086400,"startTime":"0","endTime":"0","summary":"The BBC’s decision to drop sport bulletins is lesson for sector The BBC’s decision to drop lunchtime and overnight sports bulletins from its news channel has rightly had a few journalists loosening their collars. Savings must be found, but will people miss the content?Anyone who follows football transfers spends more time on Fabrizio Romano’s social media channels than most of their relatives. And football fans will happily spend an hour listening to someone who knows their club down to the physio’s second cousin twice removed. Getting them to wait until lunchtime for an update, however, feels positively archaic when they have already spent the morning arguing about it on X.Itchy trigger fingerLive rights are still a formidable advantage. Broadcasters can pull millions of eyeballs onto a TV screen at the same time, with the scale and production expertise that blow independent channels out of the water. But the BBC are also bound to reach beyond the most zealous of fans. A YouTube chann","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/10/GettyImages-2199824975-e1790934502509.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/10/GettyImages-2199824975-e1790934502509.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/the-bbcs-bulletin-cuts-show-how-crowded-sports-broadcasting-has-become/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/the-bbcs-bulletin-cuts-show-how-crowded-sports-broadcasting-has-become/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672741591","title":"BioAge Labs initiates Phase 2 trial for BGE-102","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741591","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741591?lang=en_us&edition=fundamental","pubTime":"2026-10-03 04:54","pubTimestamp":1790974488,"startTime":"0","endTime":"0","summary":"BioAge Labs, Inc. ( ($BIOA) ) just unveiled an update. BioAge Labs announced that the first participant has been dosed in QUELL-DME, a randomized, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioage-labs-initiates-phase-2-trial-for-bge-102?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioage-labs-initiates-phase-2-trial-for-bge-102?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BBC","BIOA","PSIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672163957","title":"Abogen announces licensing, option agreement with Novartis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672163957","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672163957?lang=en_us&edition=fundamental","pubTime":"2026-10-02 18:10","pubTimestamp":1790935812,"startTime":"0","endTime":"0","summary":"Abogen Biosciences, a clinical-stage biotechnology group pioneering RNA innovation, announced that it has entered into a licensing and option agree...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abogen-announces-licensing-option-agreement-with-novartis-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","FHLC","LNGR","DARP","XT","BK4585","BBP","JDOC","IEIH","BBC","BK4505","IBB","BK4139","RSPH","BK4588","SYNB","FWD","IE0009354923.USD","RNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152338036","title":"UK Prime Minister Says Iran May Be Linked to Security Incident at RAF Fairford Air Base","url":"https://stock-news.laohu8.com/highlight/detail?id=1152338036","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152338036?lang=en_us&edition=fundamental","pubTime":"2026-10-01 01:12","pubTimestamp":1790788330,"startTime":"0","endTime":"0","summary":"UK Prime Minister Burnham has stated that the UK government believes the Iranian government was involved in a security incident at RAF Fairford air base.Five men were arrested on Sunday on suspicion...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671204298","title":"Verrica Pharmaceuticals to present new YCANTH data at upcoming conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2671204298","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671204298?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:36","pubTimestamp":1790771793,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals (VRCA) announced that it will present posters on a new analysis of Phase 3 trials of YCANTH and an encore presentation of d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/verrica-pharmaceuticals-to-present-new-ycanth-data-at-upcoming-conferences-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/verrica-pharmaceuticals-to-present-new-ycanth-data-at-upcoming-conferences-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VRCA","BBC","PSIL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671209135","title":"Jade Biosciences advances JADE301 toward Phase 1 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671209135","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671209135?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:28","pubTimestamp":1790767727,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Jade Biosciences ( ($JBIO) ). On September 30, 2026, Jade Biosciences reported preclinical data for JADE301, sh...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-advances-jade301-toward-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jade-biosciences-advances-jade301-toward-phase-1-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BBC","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671116862","title":"Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2671116862","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671116862?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:49","pubTimestamp":1790682559,"startTime":"0","endTime":"0","summary":"The latest update is out from Invivyd ( ($IVVD) ). Invivyd, Inc. is a clinical-stage biotech company developing antiviral monoclonal antibodies, le...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670605236","title":"MediciNova reports results from MN-001-NATG-202 Phase 2 trial of MN-001","url":"https://stock-news.laohu8.com/highlight/detail?id=2670605236","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670605236?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:15","pubTimestamp":1790590507,"startTime":"0","endTime":"0","summary":"MediciNova (MNOV) announced the topline results from MN-001-NATG-202, a Phase 2 clinical trial evaluating MN-001 for the treatment of hypertriglyce...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicinova-reports-results-from-mn-001-natg-202-phase-2-trial-of-mn-001-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicinova-reports-results-from-mn-001-natg-202-phase-2-trial-of-mn-001-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IDNA","MNOV","GDOC","HYLG","PSIL","NVIB","MEDX","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442737","title":"C4 Therapeutics Reports New Cemsidomide Myeloma Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442737","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442737?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:27","pubTimestamp":1790335653,"startTime":"0","endTime":"0","summary":"C4 Therapeutics ( ($CCCC) ) has issued an announcement. On September 25, 2026, C4 Therapeutics presented new biomarker data from its Phase 1 trial ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/c4-therapeutics-reports-new-cemsidomide-myeloma-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/c4-therapeutics-reports-new-cemsidomide-myeloma-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CCCC","BBC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670492925","title":"Viking Therapeutics Advances VK2735 Obesity Trial, Keeping VKTX in the Weight Loss Race","url":"https://stock-news.laohu8.com/highlight/detail?id=2670492925","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670492925?lang=en_us&edition=fundamental","pubTime":"2026-09-25 00:31","pubTimestamp":1790267475,"startTime":"0","endTime":"0","summary":"Viking Therapeutics ($VKTX) announced an update on their ongoing clinical study. Viking Therapeutics, Inc. is running a Phase 1 trial called “A Pha...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-advances-vk2735-obesity-trial-keeping-vktx-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/viking-therapeutics-advances-vk2735-obesity-trial-keeping-vktx-in-the-weight-loss-race?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","OZEM","BK4585","VKTX","THNR","BK4599","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669449944","title":"Psychedelic: Optimi completes psilocybin production for Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669449944","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669449944?lang=en_us&edition=fundamental","pubTime":"2026-09-24 22:30","pubTimestamp":1790260228,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a production completion, a strate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-completes-psilocybin-production-for-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/psychedelic-optimi-completes-psilocybin-production-for-phase-2-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669480110","title":"BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2669480110","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669480110?lang=en_us&edition=fundamental","pubTime":"2026-09-24 00:31","pubTimestamp":1790181069,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines has launched a Phase 3 trial titled “A Randomized, Open...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-phase-3-liver-cancer-trial-with-bgb-b2033?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-phase-3-liver-cancer-trial-with-bgb-b2033?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","MDCO","BBC","BGB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488235","title":"AC Immune Posts Strong Week-100 Phase 2 Data for Parkinson’s Vaccine ACI-7104","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488235","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488235?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:28","pubTimestamp":1790162930,"startTime":"0","endTime":"0","summary":"AC Immune SA ( ($ACIU) ) has shared an announcement. On September 23, 2026, AC Immune reported that Part 1 of its VacSYn Phase 2 trial of ACI-7104 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ac-immune-posts-strong-week-100-phase-2-data-for-parkinsons-vaccine-aci-7104?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ac-immune-posts-strong-week-100-phase-2-data-for-parkinsons-vaccine-aci-7104?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BK4113","ACI","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126381","title":"Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126381","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126381?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:30","pubTimestamp":1790094635,"startTime":"0","endTime":"0","summary":"Sanofi SA ($SNY) announced an update on their ongoing clinical study. Sanofi (SNY) is running a Phase 3 trial in China to test an investigational f...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sanofis-chinese-pediatric-meningococcal-vaccine-trial-advances-sharpening-long-term-growth-prospects-for-sny?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sanofis-chinese-pediatric-meningococcal-vaccine-trial-advances-sharpening-long-term-growth-prospects-for-sny?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SNY","PSIL","BBC","BK4007","IE00BFXG1179.USD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144262","title":"Adagene Wins NMPA IND Clearance for Novel HER2xCD3 T-Cell Engager ADG138","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144262","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144262?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080070,"startTime":"0","endTime":"0","summary":"Adagene ( ($ADAG) ) has issued an announcement. Adagene Inc., a platform-driven, clinical-stage biotechnology company listed on Nasdaq, specializes...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-wins-nmpa-ind-clearance-for-novel-her2xcd3-t-cell-engager-adg138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","BK4588","AGNG","BBC","IBB","SYNB","BK4585","FHLC","LNGR","JDOC","XT","FWD","LCLG","IEIH","BK4139","ADAG","NQmain","BBP","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669661341","title":"Avalyn Pharma announces published results from Phase 1 trials of AP02","url":"https://stock-news.laohu8.com/highlight/detail?id=2669661341","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669661341?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:10","pubTimestamp":1789996248,"startTime":"0","endTime":"0","summary":"Avalyn Pharma (AVLN) announced that Respiratory Research has published detailed results from two Phase 1 clinical trials of AP02 in healthy volunte...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-announces-published-results-from-phase-1-trials-of-ap02-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/avalyn-pharma-announces-published-results-from-phase-1-trials-of-ap02-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","GDOC","MEDX","NVIB","BMED","HYLG","BBC","AVLN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669684681","title":"Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2669684681","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669684681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:27","pubTimestamp":1789990051,"startTime":"0","endTime":"0","summary":"Tiziana Life Sciences ( ($TLSA) ) has shared an announcement. Tiziana Life Sciences Ltd, a clinical-stage biotechnology company specializing in imm...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tiziana-life-sciences-completes-last-patient-visit-in-phase-2a-inform-ms-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","BK4588","BBC","FWD","IBB","RSPH","IEIH","BBP","DARP","JDOC","XT","LNGR","BK4585","AGNG","FHLC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668318487","title":"Cue Biopharma announces Phase 2 trial of CUE-221 met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2668318487","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668318487?lang=en_us&edition=fundamental","pubTime":"2026-09-20 22:15","pubTimestamp":1789913705,"startTime":"0","endTime":"0","summary":"Cue Biopharma (CUE) announced positive topline results from the Phase 2 clinical trial of CUE-221 conducted in China by Genesis Life Sciences, a re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cue-biopharma-announces-phase-2-trial-of-cue-221-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cue-biopharma-announces-phase-2-trial-of-cue-221-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","BBC","CUE","NVIB","PSIL","HYLG","MEDX","BK4139","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148504480","title":"US Claims Permanent Control While Denmark Rejects Sovereignty Transfer: Who Truly Benefits from the Greenland Deal?","url":"https://stock-news.laohu8.com/highlight/detail?id=1148504480","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148504480?lang=en_us&edition=fundamental","pubTime":"2026-09-20 07:30","pubTimestamp":1789860634,"startTime":"0","endTime":"0","summary":"The United States, Denmark, and Greenland's government announced on the 18th that they had reached an agreement concerning Greenland's security, although the deal's text has yet to be released....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668180509","title":"Alterity Therapeutics to Spotlight MSA Program at ASX SMIDcaps Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2668180509","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668180509?lang=en_us&edition=fundamental","pubTime":"2026-09-18 07:48","pubTimestamp":1789688927,"startTime":"0","endTime":"0","summary":"Alterity Therapeutics ( ($AU:ATH) ) has shared an update. Alterity Therapeutics, a clinical-stage biotechnology company, develops disease-modifying...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-asx-smidcaps-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alterity-therapeutics-to-spotlight-msa-program-at-asx-smidcaps-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FHLC","BK4585","FWD","BK4539","BK4588","LENZ","BK4139","BBP","IEIH","RSPH","BK4007","BBC","IBB","DARP","LNGR","JDOC","XT","AGNG","SYNB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":161,"code":"91000000","status":"200"}]}}